Milliren CE, Evans CR, Richmond TK, Dunn EC. Does an uneven sample size distribution across settings matter in cross-classified multilevel modeling? Results of a simulation study. Health Place. 2018;52:121-126. doi:10.1016/j.healthplace.2018.05.009.

Fuchsberger C, Flannick J, Teslovich TM, et al. The genetic architecture of type 2 diabetes. Nature. 2016;536(7614):41-7. doi:10.1038/nature18642.

Bergen SE, Petryshen TL. Genome-wide association studies of schizophrenia: does bigger lead to better results?. Curr Opin Psychiatry. 2012;25(2):76-82. doi:10.1097/YCO.0b013e32835035dd.

Williams AL, Patterson N, Glessner J, Hakonarson H, Reich D. Phasing of many thousands of genotyped samples. Am J Hum Genet. 2012;91(2):238-51. doi:10.1016/j.ajhg.2012.06.013.

Adiconis X, Borges-Rivera D, Satija R, et al. Comparative analysis of RNA sequencing methods for degraded or low-input samples. Nat Methods. 2013;10(7):623-9. doi:10.1038/nmeth.2483.

Lawrence MS, Stojanov P, Polak P, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499(7457):214-218. doi:10.1038/nature12213.

Brion M-JA, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2013;42(5):1497-501. doi:10.1093/ije/dyt179.

Lawrence MS, Stojanov P, Mermel CH, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 2014;505(7484):495-501. doi:10.1038/nature12912.

Skates SJ, Gillette MA, LaBaer J, et al. Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies. J Proteome Res. 2013;12(12):5383-94. doi:10.1021/pr400132j.

Bulik-Sullivan BK, Loh P-R, Finucane HK, et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet. 2015;47(3):291-5. doi:10.1038/ng.3211.